Kowa strikes pitavastatin alliance for new Asian markets
This article was originally published in Scrip
Executive Summary
Mitsubishi Tanabe Pharma (MTP) is to develop and commercialise Kowa's hypolipaemic pitavastatin in Taiwan and Indonesia, on undisclosed financial terms.